[1]Patent:CN105399742,2016,A.Locationinpatent:Paragraph0050;0051;0052;0053;0058;0059;0060
[2]Patent:WO2015/104602,2015,A3.Locationinpatent:Page/Pagecolumn30
[1]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3Locationinpatent:Page/Pagecolumn31
[2]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0050
[1]Yan,Xin;Bain,RyanM.;Li,Yafeng;Qiu,Ran;Flick,TawnyaG.;Cooks,R.Graham[OrganicProcessResearchandDevelopment,2016,vol.20,#5,p.940-947]
[2]CurrentPatentAssignee:HAIMENBAIKANGPHARMACEUTICAL-CN105503878,2016,A
[3]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2015/104602,2015,A3
[1]CurrentPatentAssignee:SUZUKENCOLTD-US2015/239890,2015,A1Locationinpatent:Paragraph0051
Title: Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor.
Journal: Bioorganic & medicinal chemistry 20111201